Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.
Ontology highlight
ABSTRACT: Patient safety is a primary priority in the conduction of retinal gene therapy trials. An understanding of risk factors and mitigation strategies for post-procedure complications is crucial for the optimization of gene therapy clinical trial protocols. In this review, we synthesize the literature on ocular delivery methods, vector platforms, and treatment-emergent adverse effects in recent gene therapy clinical trials for inherited retinal diseases.
SUBMITTER: Nuzbrokh Y
PROVIDER: S-EPMC7708583 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA